In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics
- PMID: 2126695
- PMCID: PMC171944
- DOI: 10.1128/AAC.34.9.1839
In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics
Abstract
Dirithromycin inhibited Streptococcus pyogenes, Streptococcus pneumoniae, and other hemolytic streptococci at concentrations of less than or equal to 0.03 to 0.12 micrograms/ml, with 90% inhibition at 0.12 micrograms/ml, which is comparable to results using erythromycin. Group A streptococci, listeriae, and enterococci resistant to erythromycin were resistant to dirithromycin. Erythromycin-susceptible staphylococci were inhibited by 0.5 micrograms/ml, but for erythromycin-resistant isolates MICs were greater than or equal to 8 micrograms/ml. For Haemophilus influenzae, MICs were greater than or equal to 8 micrograms/ml, two- to fourfold greater than for erythromycin. The activity of dirithromycin against staphylococci and streptococci was not decreased by the addition of human serum.
Similar articles
-
In vitro activities of macrolides against gram-positive aerobes, Haemophilus influenzae, Moraxella catarrhalis and Bacteroides fragilis in Taiwan.Zhonghua Yi Xue Za Zhi (Taipei). 1999 Apr;62(4):230-5. Zhonghua Yi Xue Za Zhi (Taipei). 1999. PMID: 10367484
-
Macrolides resistance of common bacteria isolated from Taiwan.Diagn Microbiol Infect Dis. 1995 Dec;23(4):147-54. doi: 10.1016/0732-8893(95)00197-2. Diagn Microbiol Infect Dis. 1995. PMID: 9407220
-
Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.Diagn Microbiol Infect Dis. 1999 Apr;33(4):275-82. Diagn Microbiol Infect Dis. 1999. PMID: 10212755
-
Macrolide resistance in Streptococci and Haemophilus influenzae.Clin Lab Med. 2004 Jun;24(2):455-75. doi: 10.1016/j.cll.2004.03.006. Clin Lab Med. 2004. PMID: 15177849 Review.
-
New directions for macrolide antibiotics: structural modifications and in vitro activity.Antimicrob Agents Chemother. 1989 Sep;33(9):1413-8. doi: 10.1128/AAC.33.9.1413. Antimicrob Agents Chemother. 1989. PMID: 2684004 Free PMC article. Review. No abstract available.
Cited by
-
Comparison of dirithromycin and penicillin for treatment of streptococcal pharyngitis.Antimicrob Agents Chemother. 1997 Jan;41(1):72-5. doi: 10.1128/AAC.41.1.72. Antimicrob Agents Chemother. 1997. PMID: 8980757 Free PMC article. Clinical Trial.
-
In vitro activity of dirithromycin against Chlamydia trachomatis.Antimicrob Agents Chemother. 1994 Sep;38(9):2213-4. doi: 10.1128/AAC.38.9.2213. Antimicrob Agents Chemother. 1994. PMID: 7811051 Free PMC article.
-
Penetration of cefprozil into middle ear fluid of patients with otitis media.Antimicrob Agents Chemother. 1994 Sep;38(9):2210-2. doi: 10.1128/AAC.38.9.2210. Antimicrob Agents Chemother. 1994. PMID: 7811050 Free PMC article. Clinical Trial.
-
Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin.Antimicrob Agents Chemother. 1991 Jun;35(6):1116-26. doi: 10.1128/AAC.35.6.1116. Antimicrob Agents Chemother. 1991. PMID: 1929252 Free PMC article.
-
Choosing the right macrolide antibiotic. A guide to selection.Drugs. 1997 Mar;53(3):349-57. doi: 10.2165/00003495-199753030-00002. Drugs. 1997. PMID: 9074839 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical